World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

Annals of Family Medicine: Bleeding Risk Exceeds Clotting Risk in Patients With Cancer Near the End of Life

Cision PR Newswire by Cision PR Newswire
April 1, 2026
in Press Releases - Lifestyle
Reading Time: 4 mins read
0
Share on FacebookShare on Twitter

Most patients taking blood thinners continued treatment until death or stopped only shortly beforehand, study finds

PROVIDENCE, R.I., April 1, 2026 /PRNewswire/ — Bleeding events were far more common than clotting events among patients with cancer in the last phase of life, yet most patients taking blood-thinning medications continued treatment until death or stopped only shortly beforehand, according to a study in Annals of Family Medicine.


This infographic shows key findings for the study. One-third of patients with cancer used antithrombotic therapy at the initiation of GP palliative care, with most continuing treatment until death or discontinuing shortly before death. Bleeding events largely outnumbered clotting events among both antithrombotic therapy  users and non-users.

Blood thinners, also called antithrombotic medications, help prevent blood clots but also increase the risk of bleeding, which can be distressing and burdensome for patients. Clinicians and families often face difficult decisions about whether to continue these medications as patients approach the end of life.

Researchers examined bleeding, blood thinner use, and related events in patients with cancer during the last phase of life using routine general practitioner (GP) records from 2018 to 2022 in the Netherlands. They analyzed data from 2,860 adults starting when the GP first registered palliative care and reviewed records until death or their last GP visit. The median observation period was about six weeks.

At the start of this period, about one-third of patients were using blood thinners. Most continued treatment. Only about one in five discontinued therapy, typically shortly before death, with a median of eight days between discontinuation and death. Recognition of the terminal phase was the most commonly recorded reason for stopping treatment. Bleeding was recorded in 28.5% of patients using blood thinners and 22.0% of nonusers. Venous clots were far less common, occurring in 3.1% of users and 3.0% of nonusers. Researchers found that bleeding events were frequently missed in diagnosis codes. Manual review of clinical notes identified bleeding in 28.5% of blood-thinner users, while diagnosis codes captured 3.7%.

Bleeding events outnumbered clotting events in both patients taking blood thinners and those not taking them, yet most patients continued these medications until death or shortly before death. The findings describe how antithrombotic therapy is used in primary care for patients with cancer during the last phase of life and highlight the need to weigh the benefits and harms of continuing these medications.

Article Cited:

Antithrombotic Therapy Discontinuation, Bleeding, and Thromboembolic Events in Patients With Cancer During the Last Phase of Life: Insights From Primary Care Records

D. Abbel, MSc; G. J. Geersing, MD, PhD; E. M. Trinks-Roerdink, MD, PhD; S. J. Aldridge, PhD; A. Edwards, MD, PhD; E. C. T. Geijteman, MD, PhD; J. Goedegebuur, MD; J. Gussekloo, MD, PhD; E. K. Kempers, BSc; F. A. Klok, MD, PhD; M. J. H. A. Kruip, MD, PhD; I. Mahé, MD, PhD; S. P. Mooijaart, MD, PhD; S. Noble, MD, PhD; A. G. Ording, MSc, PhD; J. E. A. Portielje, MD, PhD; S. Szmit, MD, PhD; M. Søgaard, DVM, PhD; S. Trompet, MSc, PhD; S. C. Cannegieter, MD, PhD; and C. J. van den Dries, MD, PhD

Annals of Family Medicine is an open access, peer-reviewed, indexed research journal that provides a cross-disciplinary forum for new, evidence-based information affecting the primary care disciplines. Launched in May 2003, Annals of Family Medicine is sponsored by six family medical organizations, including the American Academy of Family Physicians, the American Board of Family Medicine, the Society of Teachers of Family Medicine, the Association of Departments of Family Medicine, the Association of Family Medicine Residency Directors, and the North American Primary Care Research Group. Annals of Family Medicine is published online six times each year, charges no fee for publication, and contains original research from the clinical, biomedical, social, and health services areas, as well as contributions on methodology and theory, selected reviews, essays, and editorials. Complete editorial content and interactive discussion groups for each published article can be accessed for free on the journal’s website, www.AnnFamMed.org.


(PRNewsfoto/Annals of Family Medicine)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/annals-of-family-medicine-bleeding-risk-exceeds-clotting-risk-in-patients-with-cancer-near-the-end-of-life-302731477.html

SOURCE Annals of Family Medicine

Cision PR Newswire

Cision PR Newswire

Related Posts

The One Where SHEGLAM Meets FRIENDS

October 26, 2026

Rapidus and HCLTech announce partnership for next-generation semiconductor technologies

October 26, 2026

Parloa’s Agent Management Platform now sold as an SAP Solution Extension for agentic customer interactions

October 26, 2026

Temu Partners with Spain’s Recyclia to Support Seller Extended Producer Responsibility

October 26, 2026

SUNON Brings AI, Nature and Human-Centered Design to ORGATEC 2026

October 26, 2026

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

October 26, 2026

Popular News

  • How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

    0 shares
    Share 0 Tweet 0
  • Mendez & Sanchez Finds Three Counties Accounted for Nearly Two-Thirds of California Rideshare Trips

    0 shares
    Share 0 Tweet 0
  • Highmark Health Reports Revenue of $26.5 billion, $741 million in Operating Income, for Nine Months ended Sept. 30, 2026

    0 shares
    Share 0 Tweet 0
  • AZ Blue Health Choice Expands Access to Resources for Page Families

    0 shares
    Share 0 Tweet 0
  • Payoneer Receives OCC Conditional Approval to Form Stablecoin National Trust Bank

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler